Jump to content

Buclizine

From Wikipedia, the free encyclopedia
Buclizine
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.001.317 Edit this at Wikidata
Chemical and physical data
FormulaC28H33ClN2
Molar mass433.04 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
 ☒NcheckY (what is this?)  (verify)

Buclizine is an antihistamine and anticholinergic of the diphenylmethylpiperazine group. It is considered to be an antiemetic, similar to meclizine.[1]

In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare for migraines.[2]

References

[edit]
  1. ^ Mostafa GA, Al-Badr AA (2011). Buclizine. Profiles of Drug Substances, Excipients and Related Methodology. Vol. 36. pp. 1–33. doi:10.1016/B978-0-12-387667-6.00001-4. ISBN 9780123876676. PMID 22469258. {{cite book}}: |journal= ignored (help)
  2. ^ Behrendt WA, Cserepes J (1985). "Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol ('Migraleve') in tablet and suppository form in rats". Pharmatherapeutica. 4 (5): 322–31. PMID 4070325.